Growth Metrics

Solid Biosciences (SLDB) Non Operating Income (2017 - 2026)

Quarterly results put Non Operating Income at $571000.0 for Q1 2026, up 203.72% from a year ago — trailing twelve months through Mar 2026 was $7.3 million (up 3908.74% YoY), and the annual figure for FY2025 was $4.9 million, down 2.98%.

Solid Biosciences has reported Non Operating Income over the past 10 years, most recently at $571000.0 for Q1 2026.

  • Non Operating Income reached $571000.0 in Q1 2026 per SLDB's latest filing, down from $4.3 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $19.4 million in Q4 2022 and bottomed at -$5.2 million in Q4 2023.
  • Median Non Operating Income over the past 5 years was $722000.0 (2022), compared with a mean of $1.8 million.
  • The largest annual shift saw Non Operating Income skyrocketed 88350.0% in 2022 before it tumbled 126.85% in 2023.
  • Over 5 years, Non Operating Income stood at $19.4 million in 2022, then plummeted by 126.85% to -$5.2 million in 2023, then skyrocketed by 48.19% to -$2.7 million in 2024, then skyrocketed by 258.31% to $4.3 million in 2025, then plummeted by 86.65% to $571000.0 in 2026.
  • Business Quant data shows Non Operating Income for SLDB at $571000.0 in Q1 2026, $4.3 million in Q4 2025, and $2.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Quantum Biopharma 1,384,976.65 Bn 1,384,976.64 Bn - -
2 Alterity Therapeutics 777,208.84 Bn 777,208.81 Bn - -
3 Legend Biotech 2,801.00 Bn 2,800.10 Bn 242.10 Mn -
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 605.66 Bn 605.66 Bn - 444,000.00
6 Vertex Pharmaceuticals 110.17 Bn 102.92 Bn 2.59 Bn -
7 Regeneron Pharmaceuticals 66.86 Bn 58.11 Bn 3.31 Bn 201.20 Mn
8 Evaxion A 65.12 Bn 65.10 Bn - -
9 Alnylam Pharmaceuticals 39.94 Bn 36.94 Bn 959.66 Mn -46.98 Mn
10 Solid Biosciences 713.77 Mn 333.09 Mn - 571,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 571,000.00
Dec 31, 2025 4.28 Mn
Sep 30, 2025 2.28 Mn
Jun 30, 2025 207,000.00
Mar 31, 2025 188,000.00
Dec 31, 2024 -2.70 Mn
Sep 30, 2024 2.46 Mn
Jun 30, 2024 239,000.00
Mar 31, 2024 2.56 Mn
Dec 31, 2023 -5.21 Mn
Sep 30, 2023 2.13 Mn
Jun 30, 2023 2.21 Mn
Mar 31, 2023 1.96 Mn
Dec 31, 2022 19.42 Mn
Sep 30, 2022 722,000.00
Jun 30, 2022 -3,000.00
Mar 31, 2022 44,000.00
Dec 31, 2021 -22,000.00
Sep 30, 2021 48,000.00
Jun 30, 2021 -10,000.00
Mar 31, 2021 -14,000.00
Dec 31, 2020 -16,000.00
Sep 30, 2020 -20,000.00
Jun 30, 2020 -13,000.00
Mar 31, 2020 165,000.00
Dec 31, 2019 469,000.00
Sep 30, 2019 462,000.00
Jun 30, 2019 444,000.00
Mar 31, 2019 720,000.00
Dec 31, 2018 702,000.00
Sep 30, 2018 38,000.00
Jun 30, 2018 118,000.00
Mar 31, 2018 31,000.00
Dec 31, 2017 93,000.00
Sep 30, 2017 228,000.00
Jun 30, 2017 576,000.00
Mar 31, 2017 238,000.00